Developments in Pharmaceutical and Biotech Patent Law 2016

San Francisco, CA

Stephanie Skaff to speak at PLI's Developments in Pharmaceutical and Biotech Patent Law 2016 seminar in San Francisco.


Pharmaceutical and biotech patent law is an important and rapidly changing practice area, and the program is designed to give you the information you need to maintain your practice edge, concentrating on new developments from 2015 and 2016, and placing them in the context of constantly evolving areas of the law.

Technological innovation, Federal Circuit appellate oversight, and Supreme Court decisions continue to drive significant changes in the law. Several different perspectives on many of the most pressing issues will be offered from very experienced practitioners.

Do not miss this opportunity to fully understand the impact of new appellate decisions on your pharmaceutical and biotechnology patent practice.

What You Will Learn

  • Biosimilars: the biosimilar approval process, regulatory exclusivity and patent litigation over biosimilar applications
  • The Supreme Court’s unmaking the law of willfulness: a return patent opinions and uncertainty
  • Continued development of patentable subject matter jurisprudence under Section 101 and an update on USPTO Patentability Guidelines for patentable subject matter
  • Litigating life sciences patent cases in district courts: strategies for fact and expert discovery, effective Markman presentations and technology tutorials, summary judgment and trial
  • Ethical considerations impacting patent practice

Special Feature:

  • Earn One Hour of Ethics Credit

Firm Highlights


Jeff Fisher Named Among Top Trade Secrets Lawyers in California by the Daily Journal

Farella Braun + Martel is proud to announce that Jeffrey M. Fisher was named among 2021’s “Top Trade Secrets Lawyers” in California by the Daily Journal . Jeff is an accomplished trial lawyer with...

Read More

Data Center Business Deals Gone Bad, and the Risks of the “Known in the Industry” Defense

Exploring business partnerships often involves or even requires sharing highly confidential trade secret information. The data center industry is no exception, and its participants have in recent years faced litigation focused around the intellectual...

Read More

51 Farella Lawyers Listed in The Best Lawyers in America© 2022 and Best Lawyers: Ones to Watch

Forty-six Farella Braun + Martel lawyers were selected by their peers for inclusion in the 2022 edition of The Best Lawyers in America © .  Five Farella lawyers were named to Best Lawyers: Ones to...

Read More

SCOTUS Copyright Fair Use Decision: Google vs. Oracle Recap and Takeaways

Eugene Mar and Erik Olson discuss "SCOTUS Copyright Fair Use Decision: Google vs. Oracle Recap and Takeaways." After more than a decade of litigation that included multiple trials and appeals, the Supreme Court of...

Read More

Google Wins Unanimous Verdict in Patent Case in Western District of Texas

Farella Braun + Martel client Google LLC won a complete defense verdict from a Texas federal jury in the Western District of Texas on October 6. At issue were allegations that Google's Nest Hub...

Read More

Farella Braun + Martel Earns 2022 U.S. News – Best Lawyers® "Best Law Firms" Rankings

Northern California legal powerhouse Farella Braun + Martel earned national and regional rankings across several practice areas in the 2022 edition of U.S. News – Best Lawyers ® "Best Law Firms." The U.S. News...

Read More

No Quarter: What Claims Doesn’t Section 230 of the Communications Decency Act Protect Platform Companies Against?

Depending on what you read or who you talk to, Section 230 of the Communications Decency Act (47 U.S.C. § 230) (CDA) is either a tool of censorship, a shield of Big Tech that...

Read More